HNHAF(HNHAF)
HNHAF
No analyst ratings available
No analyst price targets available for HNHAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $10.28T | $12.76T | $15.65T |
| Low | $9.53T | $10.02T | $13.29T |
| High | $10.97T | $15.61T | $18.05T |
| EBITDA Avg | $496.72B | $616.40B | $756.24B |
| Low | $460.67B | $484.22B | $642.23B |
| High | $530.13B | $754.20B | $872.25B |
| EBIT Avg | $376.16B | $466.79B | $572.69B |
| Low | $348.85B | $366.69B | $486.35B |
| High | $401.45B | $571.14B | $660.53B |
| Net Income Avg | $249.96B | $303.51B | $352.92B |
| Low | $200.97B | $244.02B | $283.75B |
| High | $299.81B | $364.03B | $423.30B |
| EPS Avg | $17.69 | $21.48 | $24.98 |
| Low | $14.22 | $17.27 | $20.08 |
| High | $21.22 | $25.76 | $29.96 |
| Analysts (Rev / EPS) | 18 / 1 | 19 / 1 | 8 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.69T | $3.22T | $2.78T | $2.96T | $3.26T | $3.64T |
| Low | $2.48T | $2.97T | $2.56T | $2.73T | $3.01T | $3.36T |
| High | $2.95T | $3.53T | $3.05T | $3.25T | $3.58T | $3.99T |
| EBITDA Avg | $129.94B | $155.39B | $134.22B | $143.09B | $157.55B | $175.74B |
| Low | $119.88B | $143.37B | $123.83B | $132.02B | $145.37B | $162.14B |
| High | $142.49B | $170.40B | $147.18B | $156.91B | $172.77B | $192.71B |
| EBIT Avg | $98.40B | $117.68B | $101.64B | $108.36B | $119.31B | $133.09B |
| Low | $90.79B | $108.57B | $93.78B | $99.97B | $110.08B | $122.79B |
| High | $107.90B | $129.04B | $111.46B | $118.82B | $130.84B | $145.94B |
| Net Income Avg | $75.20B | $85.62B | $73.29B | $79.23B | $88.03B | $98.18B |
| Low | $67.64B | $77.01B | $65.92B | $71.26B | $79.18B | $88.31B |
| High | $84.64B | $96.37B | $82.49B | $89.18B | $99.09B | $110.51B |
| EPS Avg | $4.70 | $5.35 | $4.58 | $4.95 | $5.50 | $6.14 |
| Low | $4.23 | $4.81 | $4.12 | $4.45 | $4.95 | $5.52 |
| High | $5.29 | $6.02 | $5.16 | $5.57 | $6.19 | $6.91 |
| Analysts (Rev / EPS) | 13 / 1 | 6 / 1 | 6 / 1 | 6 / 1 | 6 / 1 | 6 / 1 |